(NASDAQ: KOD) Kodiak Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Kodiak Sciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast KOD's revenue for 2024 to be $3,256,583,496, with the lowest KOD revenue forecast at $3,256,583,496, and the highest KOD revenue forecast at $3,256,583,496. On average, 1 Wall Street analysts forecast KOD's revenue for 2025 to be $20,455,250,995, with the lowest KOD revenue forecast at $20,455,250,995, and the highest KOD revenue forecast at $20,455,250,995.
In 2026, KOD is forecast to generate $594,397,375 in revenue, with the lowest revenue forecast at $594,397,375 and the highest revenue forecast at $594,397,375.